Clinical Trials Directory

Trials / Conditions / Immunosuppressive Agents

Immunosuppressive Agents

13 registered clinical trials studyying Immunosuppressive Agents — 3 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingEduction in ImmunoSuppressive Regimen Among Kidney Transplant Recipients Patients Admitted to the Intensive Ca
NCT06881927
University Hospital, Strasbourg, FrancePhase 4
RecruitingSingle vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB
NCT06535568
Fondazione Ricerca e Innovazione Cardiovascolare ETSN/A
Enrolling By InvitationImpact of SCFA Supplementation on Gut Microbiome Composition of Kidney Transplant Recipients
NCT07024238
University Hospital, MartinN/A
CompletedModel Informed preciSion doSIng tO iNdividualise and Optimize Pharmacotherapeutic Treatment
NCT06095895
Radboud University Medical Center—
CompletedImpact of SCFA Supplementation on Metabolic Profiles in Serum and Urine of Kidney Transplant Recipients.
NCT06951581
University Hospital, MartinN/A
UnknownPrecision Drug Use of Immunosuppressants Guided by Population Pharmacokinetics/Pharmacodynamic Models in Kidne
NCT05872815
The Second Affiliated Hospital of Chongqing Medical University—
UnknownAnti-HLA Immunization And Immunosuppressive Therapy Management In Kidney Transplant Patients Returning to Dial
NCT05282875
Central Hospital, Nancy, France—
UnknownImmunosuppressants to Postoperative Infection and Death
NCT06121804
Chung Shan Medical University—
TerminatedNatural Killer Cell (CYNK-001) IV Infusion or IT Administration in Adults With Recurrent GBM
NCT04489420
Celularity IncorporatedPhase 1
TerminatedNatural Killer Cell (CYNK-001) Infusions in Adults with AML
NCT04310592
Celularity IncorporatedPhase 1
UnknownEffect of Steroids During Pneumocystis Infection Among Non HIV Immunocompromised Patients
NCT02944045
Assistance Publique - Hôpitaux de ParisPhase 3
CompletedAn Open, Single Centre, Randomised, Parallel Group Study to Investigate Three Different Immunosuppressive Regi
NCT01183247
University Hospital, Basel, SwitzerlandPhase 4
TerminatedMMF and Calcineurin Inhibitor Withdrawal in CAN
NCT00204230
University Hospital MuensterN/A